Genomic landscape of pathogenic mutation of APC, KRAS, TP53, PIK3CA, and MLH1 in Indonesian colorectal cancer
Open Access
- 16 June 2022
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 17 (6) , e0267090
Abstract
Colorectal cancer (CRC) needs several mutations to occur in various genes, and can vary widely in different individuals; hence it is essential to be discovered in a specific population. Until recently, there has been no known study describing APC, TP53, PIK3CA, KRAS, and MLH1 of CRC in Indonesian population. This study describes the nature and location of mutation in CRC patients treated at three different hospitals in Jakarta. This descriptive study was conducted on CRC patients who underwent neoadjuvant, surgical, and adjuvant therapy at RSCM, RSKJ, and MRCCC in 2017–2018. DNA analysis was performed using next-generation sequencing and aligned against GRCh38. The pathogenic variant was identified using ACMG classification and FATHMM score. Data related to behavior and survival were collected from medical records. Twenty-two subjects in which APC, TP53, and PIKCA were mutated. KRAS mutation occurred in 64%, while MLH1 in 45%. There were five mutation types: nonsense, missense, frameshift, splice-site, and silent mutation. There are four groups of co-occurring mutations: APC, TP53, PIK3CA (triple mutation/TM) alone; TM+KRAS; TM+MLH1; and TM+KRAS+MLH1, presenting different nature and survival. Indonesia has a distinct profile of pathogenic mutation, mainly presenting with locally-advanced stage with various outcomes and survival rate.Keywords
All Related Versions
This publication has 35 references indexed in Scilit:
- E‐Cadherin/β‐Catenin Complex and the Epithelial BarrierBioMed Research International, 2011
- The Chromosomal Instability Pathway in Colon CancerGastroenterology, 2010
- APC and Oncogenic KRAS Are Synergistic in Enhancing Wnt Signaling in Intestinal Tumor Formation and ProgressionGastroenterology, 2006
- The prognostic significance of K-ras, p53, and APC mutations in colorectal carcinomaGut, 2005
- Mutations in APC, Kirsten-ras, and p53—alternative genetic pathways to colorectal cancerProceedings of the National Academy of Sciences, 2002
- The ABC of APCHuman Molecular Genetics, 2001
- The Role of E-Cadherin-Catenin Complex: More Than an Intercellular Glue?Annals of Surgical Oncology, 2000
- Somatic mutations of the APC gene in colorectal tumors: mutation cluster region in the APC geneHuman Molecular Genetics, 1992
- A genetic model for colorectal tumorigenesisCell, 1990
- Genetic Alterations during Colorectal-Tumor DevelopmentNew England Journal of Medicine, 1988